Form D — BTB Therapeutics, Inc.
0002055053-25-000003 · filed 2025-12-01
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $7,402,704
- Total sold
- $3,402,704
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BTB Therapeutics, Inc.
- CIK
- 2055053
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 26281 WYNDEMERE COURT
ESCONDIDO, CA 92026 - Phone
- (858) 945-3733
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Takashi Kiyoizumi · Executive OfficerEscondido, CA Find on LinkedIn ↗
-
Nobuhiro Yagi · DirectorEscondido, CA Find on LinkedIn ↗
-
Masatoshi Hagiwara · DirectorEscondido, CA Find on LinkedIn ↗
-
David Snyder · DirectorEscondido, CA Find on LinkedIn ↗
View original on SEC EDGAR.